Obstructive sleep apnea syndrome and arterial hypertension: bidirectional relationship
- Authors: Litvin A.Y.1, Mikhailova O.O1, Elfimova E.M1, Bugaev T.D1, Chazova I.E1
-
Affiliations:
- A.L.Myasnikov Institute of Clinical Cardiology Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
- Issue: Vol 17, No 10 (2015)
- Pages: 34-39
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94343
- ID: 94343
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A. Yu Litvin
A.L.Myasnikov Institute of Clinical Cardiology Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
Email: alelitvin@yandex.ru
д-р мед. наук, рук. лаб. апноэ сна, отд. гипертонии ИКК им. А.Л.Мясникова ФГБУ РКНПК 121552, Russian Federation, Moscow, ul. 3-ia Cherepkovskaia, d. 15a
O. O Mikhailova
A.L.Myasnikov Institute of Clinical Cardiology Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federationаспирант отд. гипертонии ИКК им. А.Л.Мясникова ФГБУ РКНПК 121552, Russian Federation, Moscow, ul. 3-ia Cherepkovskaia, d. 15a
E. M Elfimova
A.L.Myasnikov Institute of Clinical Cardiology Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federationлаборант-исследователь, лаб. апноэ сна, отд. гипертонии ИКК им. А.Л.Мясникова ФГБУ РКНПК 121552, Russian Federation, Moscow, ul. 3-ia Cherepkovskaia, d. 15a
T. D Bugaev
A.L.Myasnikov Institute of Clinical Cardiology Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federationаспирант отд. гипертонии ИКК им. А.Л.Мясникова ФГБУ РКНПК 121552, Russian Federation, Moscow, ul. 3-ia Cherepkovskaia, d. 15a
I. E Chazova
A.L.Myasnikov Institute of Clinical Cardiology Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federationчл.-кор. РАН, д-р мед. наук, проф., дир. ИКК им. А.Л.Мясникова ФГБУ РКНПК 121552, Russian Federation, Moscow, ul. 3-ia Cherepkovskaia, d. 15a
References
- Lindberg E, Elmasry A, Gislason T et al. Evolution of sleep apnea syndrome in sleepy snorers: a population - based prospective study. Am J Respir Crit Care Med 1999; 159: 6024-7.
- Marin J.M, Gascon J.M, Carrizo S, Gispert J. Prevalence of sleep apnoea syndrome in the Spanish adult population. Int J Epidemiol 1997; 26: 381-6.
- Stradling J.R, Crosby J.H. Predictors and prevalence of obstructive sleep apnoea and snoring in 1,001 middle aged men. Thorax 1991; 46: 85-90.
- Young T, Palta M, Dempsey J et al. The occurrence of sleep - disordered breathing among middle - aged adults. N Engl J Med 1993, 328: 1230-5.
- Punjabi N.M, Caffo B.S, Goodwin J.L et al. Sleep - disordered breathing and mortality: a prospective cohort study. PLoS Med 2009; 6: e1000132.
- Young T, Finn L, Peppard P.E et al. Sleep disordered breathing and mortality: eighteen - year follow - up of the Wisconsin sleep cohort. Sleep 2008; 31: 1071-8.
- Gottlieb D.J, Yenokyan G, Newman A.B et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010; 122: 352-60.
- Redline S, Yenokyan G, Gottlieb D.J et al. Obstructive sleep apnea - hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 2010; 182: 269-77.
- Somers V.K, Dyken M.E, Mark A.L, Abboud F.M. Sympathetic - nerve activity during sleep in normal subjects. N Engl J Med 1993; 328: 303-7.
- Trinder J, Kleiman J, Carrington M et al. Autonomic activity during human sleep as a function of time and sleep stage. J Sleep Res 2001; 10: 253-64.
- Arzt M, Young T, Finn L et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 2006; 166: 1716-22.
- Friedman O, Bradley T.D, Ruttanaumpawan P, Logan A.G. Independent association of drug - resistant hypertension to reduced sleep duration and efficiency. Am J Hypertens 2010; 23: 174-9.
- Chiu K.L, Ryan C.M, Shiota S et al. Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med 2006; 174: 1378-83.
- Shiota S, Ryan C.M, Chiu K.L et al. Alterations in upper airway crosssectional area in response to lower body positive pressure in healthy subjects. Thorax 2007; 62: 868-72.
- Yumino D, Wang H, Floras J.S et al. Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail 2009; 15: 279-85.
- Bassetti C.L, Milanova M, Gugger M. Sleep - disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long - term clinical outcome. Stroke 2006; 37: 967-72.
- Arzt M, Young T, Peppard P.E et al. Dissociation of obstructive sleep apnea from hypersomnolence and obesity in patients with stroke. Stroke 2010; 41: e129-e134.
- Ryan C.M, Bradley T.D. Pathogenesis of obstructive sleep apnea. J Appl Physiol 2005; 99: 2440-50.
- Logan A.G, Perlikowski S.M, Mente A et al. High prevalence of unrecognized sleep apnoea in drug - resistant hypertension. J Hypertens 2001; 19: 2271-7.
- Roumelioti M.E, Buysse D.J, Sanders M.H et al. Sleep - disordered breathing and excessive daytime sleepiness in chronic kidney disease and hemodialysis. Clin J Am Soc Nephrol 2011; 6: 986-94.
- Kasai T, Arcand J, Allard J.P et al. Relationship between sodium intake and sleep apnea in patients with heart failure. J Am Coll Cardiol 2011; 58: 1970-4.
- Witkowski A, Prejbisz A, Florczak E et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 2011; 58: 559-65.
- Gaddam K, Pimenta E, Thomas S.J et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens 2010; 24: 532-7.
- Su M.C, Chiu K.L, Ruttanaumpawan P et al. Lower body positive pressure increases upper airway collapsibility in healthy subjects. Respir Physiol Neurobiol 2008; 161: 306-12.
- Redolfi S, Yumino D, Ruttanaumpawan P et al. Relationship between overnight rostral fluid shift and obstructive sleep apnea in nonobese men. Am J Respir Crit Care Med 2009; 179: 241-6.
- Yumino D, Redolfi S, Ruttanaumpawan P et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010; 121: 1598-605.
- Elias R.M, Bradley T.D, Kasai T et al. Rostral overnight fluid shift in end - stage renal disease: relationship with obstructive sleep apnea. Nephrol Dial Transplant 2012; 27: 1569-73.
- Friedman O, Bradley T.D, Chan C.T et al. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug - resistant hypertension. Hypertension 2010; 56: 1077-82.
- Jafari B, Mohsenin V. Overnight rostral fluid shift in obstructive sleep apnea: does it affect the severity of sleep - disordered breathing? Chest 2011; 140:991-7.
- Redolfi S, Arnulf I, Pottier M et al. Effects of venous compression of the legs on overnight rostral fluid shift and obstructive sleep apnea. Respir Physiol Neurobiol 2011; 175: 390-3.
- Redolfi S, Arnulf I, Pottier M et al. Attenuation of obstructive sleep apnea by compression stockings in subjects with venous insufficiency. Am J Respir Crit Care Med 2012; 184: 1062-6.
- Tang S.C, Lam B, Ku P.P et al. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler - assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2006; 17: 2607-16.
- Tang S.C, Lam B, Lai A.S et al. Improvement in sleep apnea during nocturnal peritoneal dialysis is associated with reduced airway congestion and better uremic clearance. Clin J Am Soc Nephrol 2009; 4: 410-8.
- Hanly P.J, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001; 344: 102-7.
- Bucca C.B, Brussino L, Battisti A et al. Diuretics in obstructive sleep apnea with diastolic heart failure. Chest 2007; 132: 440-6.
- Narkiewicz K, Somers V.K. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 2003; 177 (3): 385-90.
- Somers V.K, Dyken M.E, Clary M.P, Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96 (4): 1897-904.
- Narkiewicz K, van de Borne P.J, Cooley R.L et al. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998; 98 (8): 772-6.
- Carlson J.T, Hedner J, Elam M et al. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993; 103 (6): 1763-8.
- Fletcher E.C. Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea. Sleep 2003; 26 (1): 15-9.
- Phillips B.G, Somers V.K. Neural and humoral mechanisms mediating cardiovascular responses to obstructive sleep apnea. Respir Physiol 2000; 119 (2-3): 181-7.
- Brooks D, Horner R.L, Kozar L.F et al. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997; 99: 106-9.
- Spaak J, Egri Z.J, Kubo T et al. Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 2005; 46: 1327-32.
- Narkiewicz K, Montano N, Cogliati C et al. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998; 98 (11): 1071-7.
- Caples S.M, Gami A.S, Somers V.K. Obstructive sleep apnea. Ann Intern Med 2005; 142 (3): 187-97.
- Curtis B.M, O’Keefe Jr.J.H. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc 2002; 77 (1): 45-54.
- Brook R.D, Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 2000; 13 (6 Part 2): 112S-22S.
- Usui K, Bradley T.D, Spaak J et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005; 45: 2008-11.
- Gilman M.P, Floras J.S, Usui K et al. Continuous positive airway pressure increases heart rate variability in heart failure patients with obstructive sleep apnoea. Clin Sci (Lond) 2008; 114: 243-9.
- Prabhakar N.R. Sleep apneas: an oxidative stress? Am J Respir Crit Care Med 2002; 165: 859-60.
- Schulz R, Mahmoudi S, Hattar K et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162: 566-70.
- Suzuki Y.J, Jain V, Park A.M., Day R.M. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 2006; 40: 1683-92.
- Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51.
- Meier-Ewert H.K, Ridker P.M, Rifai N et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004; 43: 678-83.
- Vgontzas A.N, Papanicolaou D.A, Bixler E.O et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82: 1313-6.
- Ohga E, Tomita T, Wada H et al. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 2003; 94: 179-84.
- Minoguchi K, Yokoe T, Tazaki T et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 2007; 175: 612-7.
- Svatikova A, Wolk R, Shamsuzzaman A.S et al. Serum amyloid a in obstructive sleep apnea. Circulation 2003; 108: 1451-4.
- Shamsuzzaman A.S, Winnicki M, Lanfranchi P et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462-4.
- Larkin E.K, Rosen C.L, Kirchner H.L et al. Variation of C-reactive protein levels in adolescents: association with sleepdisordered breathing and sleep duration. Circulation 2005; 111: 1978-84.
- Punjabi N.M, Beamer B.A. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 2007; 30: 29-34.
- Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med. 2002; 165: 934-9.
- Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci 2005; 1051: 340-50.
- Drager L.F, Polotsky V.Y, Lorenzi-Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 2011; 140: 534-42.
- Kohler M, Stradling J.R. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 2010; 7: 677-85.
- Berger S, Lavie L. Endothelial progenitor cells in cardiovascular disease and hypoxia - potential implications to obstructive sleep apnea. Transl Res 2011; 158: 1-13.
- Butt M, Khair O.A, Dwivedi G et al. Myocardial perfusion by myocardial contrast echocardiography and endothelial dysfunction in obstructive sleep apnea. Hypertension 2011; 58: 417-24.
- Drager L.F, Bortolotto L.A, Figueiredo A.C et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007; 176: 706-12.
- Barcelo A, Pierola J, de la Pena M et al. Impaired circadian variation of platelet activity in patients with sleep apnea. Sleep Breath 2012; 16: 355-60.
- Chin K, Ohi M,Kita H et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996;153:1972-6.
- Von Kanel R, Loredo J.S, Ancoli-Israel S, Dimsdale J.E. Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure. Sleep Breath 2006; 10: 139-46.
- Mehra R, Xu F, Babineau D.C et al. Sleep - disordered breathing and prothrombotic biomarkers: crosssectional results of the Cleveland Family Study. Am J Respir Crit Care Med. 2010; 182: 826-33.
- Minoguchi K, Yokoe T, Tazaki T et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 2007; 175: 612-7.
- Arias M.A, Garcia-Rio F, Alonso-Fernandez A et al. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005; 112 (3): 375-83.
- Bradley T.D, Floras J.S. Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation 2003; 107 (12): 1671-8.
- Yaggi H.K, Concato J, Kernan W.N et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353 (19): 2034-41.
- Gami A.S, Pressman G, Caples S.M et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004; 110 (4): 364-7.
- Schulz R, Eisele H.J, Weissmann N, Seeger W. Pulmonary hypertension and sleep - related breathing disorders. Pneumologie 2005; 59 (4): 270-4.
- Silverberg D.S, Oksenberg A, Iaina A. Sleep - related breathing disorders as a major cause of essential hypertension: fact or fiction? Curr Opin Nephrol Hypertens 1998; 7: 353-7.
- Fletcher E.C, De Behnke R.D, Lovoi M.S, Gorin A.B. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 1985; 103: 190-5.
- Kales A, Bixler E.O, Cadieux R.J et al. Sleep apnoea in a hypertensive population. Lancet 1984; 2: 1005-8.
- Lavie P, Ben-Yosef R, Rubin A.E. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 1984; 108: 373-6.
- Vardan S, Dunsky M.H, Hill N.E et al. Systemic systolic hypertension in the elderly: correlation of hemodynamics, plasma volume, renin, aldosterone, urinary metanephrines and response to thiazide therapy. Am J Cardiol 1986; 58: 1030-4.
- Williams A.J, Houston D, Finberg S et al. Sleep apnea syndrome and essential hypertension. Am J Cardiol 1985; 55: 1019-22.
- Pratt-Ubunama M.N, Nishizaka M.K., Boedefeld R.L et al. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007; 131 (2): 453-9.
- Grote L, Hedner J, Peter J.H. Sleep - related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens 2000; 18: 679-85.
- Calhoun D.A, Nishizaka M.K, Zaman M.A, Harding S.M. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 2004; 125: 112-7.
- Goodfriend T.L, Calhoun D.A. Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 2004; 43: 518-24.
- Rocchini A.P, Katch V.L, Grekin R. Role for aldosterone in blood pressure regulation of obese adolescents. Am J Cardiol 1986; 57 (8): 613-8.
- Gonzaga C.C, Gaddam K.K, Ahmed M.I et al. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med 2010; 6 (4): 363-8.
- Fletcher E.C, Bao G. The rat as a model of chronic recurrent episodic hypoxia and effect upon systemic blood pressure. Sleep 1996; 19(10 Suppl.): S210-2.
- Hamilton G.S, Solin P, Naughton M.T. Obstructive sleep apnoea and cardiovascular disease. Intern Med J 2004; 34 (7): 420-6.
- Peppard P.E, Young T, Palta M, Skatrud J. Prospective study of the association between sleep - disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84.
- Cano-Pumarega I, Duran-Cantolla J, Aizpuru F et al. Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: the Vitoria Sleep Cohort. Am J Respir Crit Care Med 2012; 184: 1299-304.
- Pedrosa R.P, Drager L.F, Gonzaga C.C et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 2011; 58: 811-7.
- Logan A.G, Tkacova R, Perlikowski S.M et al. Refractory hypertension and sleep apnea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21: 241-7.
- Verdecchia P, Schillaci G, Guerrieri M et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-36.
- Hermida R.C, Ayala D.E, Mojon A, Fernandez J.R. Decreasing sleep - time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol 2011; 58: 1165-73.
- Martino T.A, Tata N, Simpson J.A et al. The primary benefits of angiotensin - converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy. J Am Coll Cardiol 2011; 57: 2020-8.
- Hedner J, Bengtsson-Bostrom K, Peker Y et al. Hypertension prevalence in obstructive sleep apnoea and sex: a population - based case - control study. Eur Respir J 2006; 27 (3): 564-70.
- Chobanian A.V, Bakris G.L, Black H.R et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289 (19): 2560-72.
- Bloch M.J, Basile J. Short - term treatment of sleep apnea with nocturnal continuous positive airway pressure does not improve blood pressure in patients with well controlled hypertension. J Clin Hypertens (Greenwich) 2006; 8: 673-5.
- Haentjens P, van Meerhaeghe A, Moscariello A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta - analysis of placebo - controlled randomized trials. Arch Intern Med 2007; 167: 757-64.
- Bazzano L.A, Khan Z, Reynolds K, He J. Effect of treatment with nocturnal nasal continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea. Hypertension 2007; 50: 417-23.
- Alajmi M, Mulgrew A.T, Fox J et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta - analysis of randomized controlled trials. Lung 2007; 185: 67-72.
- Iftikhara I.H, Valentineb C.W, Bittencourtc L.R.A et al. Magalangk Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a meta - analysis. J Hypertension 2014; 32 (Issue 12): 2341-50.
- Pepin J.L, Tamisier R, Barone-Rochette G et al. Сomparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 182 (7): 954-60.